These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 22445203)

  • 1. Potential protective role of linezolid against Clostridium difficile infection.
    Valerio M; Pedromingo M; Muñoz P; Alcalá L; Marin M; Peláez T; Giannella M; Bouza E
    Int J Antimicrob Agents; 2012 May; 39(5):414-9. PubMed ID: 22445203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of linezolid for the treatment of Clostridium difficile infection caused by epidemic strains using an in vitro human gut model.
    Baines SD; Noel AR; Huscroft GS; Todhunter SL; O'Connor R; Hobbs JK; Freeman J; Lovering AM; Wilcox MH
    J Antimicrob Chemother; 2011 Jul; 66(7):1537-46. PubMed ID: 21504940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of continued antibacterial therapy after diagnosis of hospital-onset Clostridium difficile infection: implications for antimicrobial stewardship.
    Harpe SE; Inocencio TJ; Pakyz AL; Oinonen MJ; Polk RE
    Pharmacotherapy; 2012 Aug; 32(8):744-54. PubMed ID: 23307522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of Clostridium difficile infections in patients receiving antimicrobial and acid-suppression therapy.
    King RN; Lager SL
    Pharmacotherapy; 2011 Jul; 31(7):642-8. PubMed ID: 21923450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A clinical risk index for Clostridium difficile infection in hospitalised patients receiving broad-spectrum antibiotics.
    Garey KW; Dao-Tran TK; Jiang ZD; Price MP; Gentry LO; Dupont HL
    J Hosp Infect; 2008 Oct; 70(2):142-7. PubMed ID: 18723249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An evaluation of the impact of antibiotic stewardship on reducing the use of high-risk antibiotics and its effect on the incidence of Clostridium difficile infection in hospital settings.
    Aldeyab MA; Kearney MP; Scott MG; Aldiab MA; Alahmadi YM; Darwish Elhajji FW; Magee FA; McElnay JC
    J Antimicrob Chemother; 2012 Dec; 67(12):2988-96. PubMed ID: 22899806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cumulative antibiotic exposures over time and the risk of Clostridium difficile infection.
    Stevens V; Dumyati G; Fine LS; Fisher SG; van Wijngaarden E
    Clin Infect Dis; 2011 Jul; 53(1):42-8. PubMed ID: 21653301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection, treatment, and prevention of Clostridium difficile infection.
    McCollum DL; Rodriguez JM
    Clin Gastroenterol Hepatol; 2012 Jun; 10(6):581-92. PubMed ID: 22433924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of Clostridium difficile infection in hospitalized patients receiving metronidazole for a non-C difficile infection.
    Rodriguez S; Hernandez MB; Tarchini G; Zaleski M; Vatanchi M; Cardona L; Castro-Pavia F; Schneider A
    Clin Gastroenterol Hepatol; 2014 Nov; 12(11):1856-61. PubMed ID: 24681079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Time interval of increased risk for Clostridium difficile infection after exposure to antibiotics.
    Hensgens MP; Goorhuis A; Dekkers OM; Kuijper EJ
    J Antimicrob Chemother; 2012 Mar; 67(3):742-8. PubMed ID: 22146873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential risk of Clostridium difficile infection with proton pump inhibitor use by level of antibiotic exposure.
    Stevens V; Dumyati G; Brown J; Wijngaarden E
    Pharmacoepidemiol Drug Saf; 2011 Oct; 20(10):1035-42. PubMed ID: 21833992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of Clostridium difficile infection after perioperative antibacterial prophylaxis before and during an outbreak of infection due to a hypervirulent strain.
    Carignan A; Allard C; Pépin J; Cossette B; Nault V; Valiquette L
    Clin Infect Dis; 2008 Jun; 46(12):1838-43. PubMed ID: 18462108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical outcomes of linezolid vs vancomycin in methicillin-resistant Staphylococcus aureus ventilator-associated pneumonia: retrospective analysis.
    Chan JD; Pham TN; Wong J; Hessel M; Cuschieri J; Neff M; Dellit TH
    J Intensive Care Med; 2011; 26(6):385-91. PubMed ID: 21606058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors of Clostridium difficile infections among patients in a university hospital in Shanghai, China.
    Huang H; Wu S; Chen R; Xu S; Fang H; Weintraub A; Nord CE
    Anaerobe; 2014 Dec; 30():65-9. PubMed ID: 25219941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of Clostridium difficile infection in patients receiving high-risk antibiotics with or without a proton pump inhibitor.
    Gordon D; Young LR; Reddy S; Bergman C; Young JD
    J Hosp Infect; 2016 Feb; 92(2):173-7. PubMed ID: 26616410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retrospective cohort chart review study of factors associated with the development of thrombocytopenia in adult Japanese patients who received intravenous linezolid therapy.
    Niwa T; Suzuki A; Sakakibara S; Kasahara S; Yasuda M; Fukao A; Matsuura K; Goto C; Murakami N; Itoh Y
    Clin Ther; 2009 Oct; 31(10):2126-33. PubMed ID: 19922883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of vancomycin dose on treatment outcomes in severe Clostridium difficile infection.
    Lam SW; Bass SN; Neuner EA; Bauer SR
    Int J Antimicrob Agents; 2013 Dec; 42(6):553-8. PubMed ID: 24103633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of guidelines and enhanced antibiotic stewardship on reducing broad-spectrum antibiotic usage and its effect on incidence of Clostridium difficile infection.
    Talpaert MJ; Gopal Rao G; Cooper BS; Wade P
    J Antimicrob Chemother; 2011 Sep; 66(9):2168-74. PubMed ID: 21676904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fecal microbiota transplantation for relapsing Clostridium difficile infection in 26 patients: methodology and results.
    Kelly CR; de Leon L; Jasutkar N
    J Clin Gastroenterol; 2012 Feb; 46(2):145-9. PubMed ID: 22157239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proton Pump Inhibitors and the Risk for Hospital-Acquired Clostridium difficile Infection.
    Barletta JF; El-Ibiary SY; Davis LE; Nguyen B; Raney CR
    Mayo Clin Proc; 2013 Oct; 88(10):1085-90. PubMed ID: 24012413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.